Benliro, Shirly T.
HRN: 24-30-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/28/2023
01/04/2024
IV
1.5gms
Q8
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes